Korea University Medical Center announces the novel cooperation of AI
Korea University Medical Center has established cooperation with Royal Philips in the field of joint research and development of solutions based on AI, supporting the diagnosis of neurological and cardiovascular disorders.
Five -year cooperation involves the establishment of an wise healthcare system, driven by Substantial Data and AI, in order to detect brain and heart disease early and personalize treatment methods.
“The combination of our possibilities of medical research and the global Philips technology network will significantly speed up development [personalised] Diagnostic solutions-the Hong-Seok Park, professor and head of the Kumc Information Center, commented.
The latest Genom of Cancer DB lives in India
Indian Institute of Technology Madras (Iit Madras) issued a publicly available cancer genome database.
Since 2020, the Institute has been selecting 960 entire exails from 480 tissue samples of patients with breast cancer.
” [Bharat Cancer Genome Atlas] It fills the gap in the genomic landscape from various cancers in the country. It provides a compendium of genetic variants representing the modern population of Indian breast cancer to classify variants involved in early diagnostics, disease progression and treatment results, “explained Veezhinathan Kamakoti, professor and director and Madras.
Similar database, The Indian genome of cancer was released last year. Initially, it includes genomic data collected from patients with breast cancer.
At the beginning of this month, the Ministry of Science and Technology launched Indian set of genomic data, which provides access to 10,000 samples of the entire genome. The ministry also shared its sequencing plan of 10 million genomes.
Kerala Gov’t Powers eye control program with AI
The Kerala government, the state on the west coast of the Indian Peninsula, has entered the next phase of the eye disease screening program.
Nayanamritham 2.0 is now equipped with optometrists with Remidio powered by Remidio in order to classify cases as reference or non -reference.
The screening program has also expanded from focusing on diabetic retinopathy to the cases of glaucoma and age -related macular degeneration. The shows now also include social health centers, Taluk hospitals and district hospitals.